Gold nanoshell bioconjugates for molecular imaging in living cells

Area of Science:

• Biomedical optics
• Nanotechnology
• Molecular imaging

Background:

• Scattering-based optical imaging offers noninvasive, real-time, high-resolution in vivo tissue imaging for cancer detection and monitoring.
• Photonics technologies present cost-effective solutions for advanced medical imaging.
• Targeted optical contrast agents are crucial for advancing the clinical potential of molecular imaging strategies.

Purpose of the Study:

• To develop and evaluate a novel class of optical contrast agents based on nanoshell bioconjugates for molecular imaging in living cells.
• To assess the advantages of nanoshells over conventional imaging probes for biomedical applications.

Main Methods:

• Synthesis and characterization of nanoshell bioconjugates.
• Utilizing nanoshell bioconjugates for targeted molecular imaging in live human breast carcinoma cells.
• Evaluating targeting efficacy against human epidermal growth factor receptor 2 (HER2).

Main Results:

• Nanoshell bioconjugates demonstrate superior properties including wavelength tunability, high scattering and absorption coefficients, chemical stability, and biocompatibility.
• Successful targeted imaging of HER2, a key breast cancer biomarker, in live cancer cells.
• Demonstrated feasibility of nanoshells as effective contrast agents for molecular imaging.

Conclusions:

• Nanoshell bioconjugates represent a promising new class of optical contrast agents for molecular imaging.
• These agents can be effectively targeted to specific biomarkers like HER2 for cancer detection.
• The developed technology holds potential for noninvasive point-of-care cancer diagnostics and monitoring.